In two Phase 3 studies, a fixed-dose combination of cagrilintide and semaglutide (each at 2.4 mg) was associated with weight reductions of 20.4% and 10.4% (placebo subtracted) after once-weekly subcutaneous injection for 68 weeks in overweight/obese individuals without and with type 2 diabetes, respectively (Table 2) [68]
Yes, there are always things we can improve on
In cases such as sports injuries, bone-joint injuries, or skin injuries, to prevent them or their recurrence, preventive intake of 1 capsule of NL-BPC-157 peptide is sufficient for people weighing up to about 100 kg and 2 capsules for those weighing over 100 kg
He added that Eli Lilly is also developing an oral version of the injectable treatment, which might be preferable for many patients
Women are already starting more businesses than men (1.5 times the national average, in fact)